Royalty Pharma plc
RPRX
Kedudukan dalam Saham
#866
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Harga Saham
$62.21
Modal Pasaran
$27.70B
Perubahan (1 hari)
3.22%
Perubahan (1 tahun)
69.83%
Negara
US
Perdagangan Royalty Pharma plc (RPRX)
Kategori
Healthcare
Bilangan saham terbitan bagi Royalty Pharma plc (RPRX)
Bilangan saham terbitan setakat June 2026: 445.06M
Menurut laporan kewangan terkini dan harga saham Royalty Pharma plc, bilangan saham terbitan semasa ialah 445.06M. Pada akhir December 2024, syarikat mempunyai 445.99M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Royalty Pharma plc (RPRX) dari 2015 hingga 2026
Saham terbitan pada akhir setiap tahun
| Tahun | Saham Terbitan | Ubah |
|---|---|---|
| 2026 (TTM) | 445.06M | 3.55% |
| 2025 | 429.80M | -3.63% |
| 2024 | 445.99M | -0.36% |
| 2023 | 447.60M | 2.20% |
| 2022 | 437.96M | 5.59% |
| 2021 | 414.79M | 6.87% |
| 2020 | 388.14M | 9.59% |
| 2019 | 354.18M | 0.00% |
| 2018 | 354.18M | 0.00% |
| 2017 | 354.18M | -41.65% |
| 2016 | 607.04M | 0.00% |
| 2015 | 607.04M | 0.00% |
Saham terbitan bagi syarikat atau pesaing yang serupa
| Syarikat | Saham Terbitan | Perbezaan | Negara |
|---|---|---|---|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| 105.38M | -76.32% |
US
|
|
| 18.05B | 3,955.26% |
HK
|
